Literature DB >> 10163570

An historical survey of UK government measures to control the NHS medicines expenditure from 1948 to 1996.

J P Griffin1.   

Abstract

Since the inception of the National Health Service in 1948, successive British governments have taken various measures to restrain the growth of the medicines bill. A total of 10 different measures have been introduced with very limited success. The most effective measures have been those directed at increasing the level of generic prescribing; such measures mean that the patient is treated with older, off-patent medicines which, although cheap, are not necessarily cost effective or the most clinically effective. Possible future directions for curtailing expenditure include controlling the price of off-patent branded medicines to the level of generic products, and the initiation of a government policy to actively encourage prescribing of newer medicines where these are shown to be more clinically effective or more cost effective.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10163570     DOI: 10.2165/00019053-199610030-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  6 in total

1.  The UK indicative prescribing scheme: background and operation.

Authors:  J Bligh; T Walley
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

Review 2.  Current prescribing in primary care in the UK. Effects of the indicative prescribing scheme and GP fundholding.

Authors:  T Walley; R Wilson; J Bligh
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

3.  Therapeutic conservatism: more costly in the long term? A UK perspective.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

4.  Generic medicines. Reducing cost at the expense of quality?

Authors:  R Walker
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

5.  Increasing cost of medicines.

Authors:  J P Griffin
Journal:  Lancet       Date:  1993-05-01       Impact factor: 79.321

6.  The economic implications of therapeutic conservatism.

Authors:  J P Griffin; T D Griffin
Journal:  J R Coll Physicians Lond       Date:  1993-04
  6 in total
  3 in total

1.  Pharmaceutical policy regarding generic drugs in Belgium.

Authors:  Steven Simoens; Kristien De Bruyn; Marc Bogaert; Gert Laekeman
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  Pharmaceutical price regulation. A study on the impact of the rate-of-return regulation in the UK.

Authors:  J R Borrell
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

Review 3.  Pharmaceutical policies: effects of financial incentives for prescribers.

Authors:  Arash Rashidian; Amir-Houshang Omidvari; Yasaman Vali; Heidrun Sturm; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2015-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.